Google wants your medical records

December 19, 2013- Interviewed by Steven E. Greer, MD

In Part 3 of our interview with Robert Klitzman, MD, ethics professor at Columbia University, Continue reading

Posted in - Biotech, - Policy, Columbia, FDA, Genetics | Leave a comment

Google’s Larry Page wants your medical records to be public for “research”

March 20, 2014-By Steven E. Greer, MD

Charlie Rose interviewed Google founder Larry Page at the 2014 TED conference. During the talk, Mr. Continue reading

Posted in - Biotech, - Medical Devices, - Opinion, Congress, Genetics | Leave a comment

Google wants your DNA now (Not just with 23andMe)

Google-founder-and-DNA-companiesOpinion December 17, 2013- By Steven E. Greer, MD

The Wall Street Journal published an article explaining how the pharmaceutical industry data mines Continue reading

Posted in - Opinion, - Policy, FDA, Genetics | Leave a comment

Apple, Google, and Amazon need to make their own hospitals

Update February 27, 2018- Well, they used my idea from two-years ago. Amazon, Warren Buffet, Continue reading

Posted in - Medical Devices, - Opinion, CMS, Congress, Z Medical centers | Leave a comment

Brigham and Women’s Hospital engages in bizarre PR campaign for daily aspirin

 April 21, 2015- By Steven E. Greer, MD

Brigham and Women’s Hospital in Boston, part of the Harvard University network of hospitals, Continue reading

Posted in - Policy, Cardiology, Harvard, Neurology, Oncology | Leave a comment

The secret agenda of Neocons: Supporting the corrupt status quo in healthcare

January 29, 2019- by Steven E. Greer, MD

Kamala Harris announced her run for president. She gave a town hall talk laying out her platform. Continue reading

Posted in - Opinion, - Policy, CMS, Congress | Leave a comment

Big Time College Sports is not the worst thing about American universities

Johnny-footballJanuary 10, 2015- By Steven E. Greer, MD

I was chuckling at an irrelevant essay in the NY Post complaining about how college football Continue reading

Posted in - Opinion, - Policy, Congress | Leave a comment

Once again, daily aspirin is shown to be deadly rather than beneficial

September 16, 2018- by Steven E. Greer, MD

The Healthcare Channel has been pounding the table for many years pushing back against the drug Continue reading

Posted in - NEJM, - Pharma, Cardiac surgery, Cardiology, Gastroenterology and liver, Geriatrics, Internal Medicine, Neurology, Neurosurgery, Oncology, Vascular Surgery | Leave a comment

Don Berwick, MD: State health insurance exchanges

April 4, 2012

Posted in CMS, Congress, Harvard | Leave a comment

Don Berwick, MD: Changing from fee-for-service to bundled payments in Medicare and Medicaid

April 4, 2012

Posted in CMS, Harvard | Leave a comment

Don Berwick, MD: National Coverage Decisions

December 1, 2013- National Coverage Decisions (NCDs) are used by CMS to set guidelines as to Continue reading

Posted in CMS, Harvard | Leave a comment

Don Berwick, MD: The Institute for Healthcare Improvement

Posted in CMS, Harvard | Leave a comment

Industry conflicts arise at PCORI threatening any real comparative effectiveness research

February 7, 2014- By Steven E. Greer, MD

The Patient Centered Outcome Research Institute (PCORI) was created by the PPACA “ObamaCare” law in 2010. Continue reading

Posted in - Medical Devices, - Opinion, - Pharma, CMS, Congress, Yale | Leave a comment

Essay: The Sad State of Affairs for American Medicine Primary Care

December 26, 2018- by Steven E. Greer, MD

I am so saddened by the state of our profession. I have been in different industries and unaware Continue reading

Posted in - Opinion, - Policy, CMS, Congress, Primary care medicine | Leave a comment

Review: “The Bleeding Edge” documentary on unsafe medical devices

November 1, 2018- by Steven E. Greer, MD

The Netflix 2018 documentary “The Bleeding Edge” reviews modern cases of medical devices Continue reading

Posted in - Medical Devices, - Reviews, books, devices, FDA | Leave a comment

Review of immunotherapy and targeted therapy

June 17, 2016- interviewed by Steven E. Greer, MD

We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma, to go over the Continue reading

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

The Year in Review: 2018

December 29, 2018- by Steven E. Greer, MD

The biggest stories this year related Continue reading

Posted in - Biotech, - Generics, - Medical Devices, - Opinion, - Pharma, - Policy, - Reviews, books, devices, - The Weekly Summary | Leave a comment

Essay: The Silos of American Healthcare Stifle Communication Between Providers

December 19, 2018- by Steven E. Greer, MD

I have a clinical practice that treats chronic conditions, among other things. I recently ran across a Continue reading

Posted in - Opinion, CMS, Congress | Leave a comment

Essay: Everything you say can and will be used against you

November 10, 2018- by Steven E. Greer, MD

I keep telling people that “smart home” devices, such as Amazon’s Alexa, record everything Continue reading

Posted in - Opinion, - Policy, Congress | Leave a comment

Insurance companies are not paying for Repatha and Praluent

Update November 2, 2018- Amgen slashed the annual cost of this drug to $6,000. Continue reading

Posted in - Biotech, - Pharma, - Policy, Cardiac surgery, Cardiology, Henry Ford, Primary care medicine | Leave a comment